A director at Sacyr S.A. sold 205,000 shares at 3.370EUR and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
NEWS SUMMARY: CAF, IBERDROLA, INDRA. Stock markets driven by tariffs and fiscal plans It was a highly volatile week following the historical rise in the German bond yield and fears of a downturn in the US, not only due to the macro data but also the impact from the tariff war. In the STOXX 600, the best-performing sectors were Chemicals and Construction, whereas Real Estate and Consumer Goods suffered the biggest drops. On the geopolitical front, Putin seems willing to sign a temporary ceasefi...
NEWS SUMMARY: ALMIRALL, CAF. The higher spending underpins stock markets and drags down fixed income European stock markets rallied, fuelled by the stimulus plans in Germany and the possible peace in Ukraine. Thus, in the STOXX 600, construction (infrastructure plans in Germany and reconstruction of Ukraine) and Banks (thanks to higher rates) were the best-performing sectors whereas bond proxies such as Real Estate, Utilities and defensive industries such as Food and Household posted the bigg...
4Q'24 vs. 4Q'23 Results Sales: € 11.931 Bn (+27.7% vs. +17.7% BS(e) and +18.2% consensus); EBITDA: € 777.0 M (+60.5% vs. +45.2% BS(e) and +47.5% consensus); EBIT: € 511.0 M (+44.4% vs. +27.9% BS(e) and +21.5% consensus); Net Profit: € 223.0 M (+9.3% vs. -10.9% BS(e) and -2.5% consensus); FY2024 vs. FY2023 Results Sales: € 41.633 Bn (+16.5% vs. +13.9% BS(e) and +14.0% consensus); EBITDA: € 2.456 Bn (+28.7% vs. +24.8% BS(e) and +25.4% consensus); EBIT: € 1.59 Bn (+19.9% vs. +15.5% BS(e) and +13.8%...
4Q'24 vs. 4Q'23 Results Sales: € 1.309 Bn (-4.1% vs. -15.5% BS(e) and -15.6% consensus); EBITDA: € 404.2 M (-25.6% vs. -34.8% BS(e) and -31.6% consensus); EBIT: € 355.0 M (-12.2% vs. -22.8% BS(e) and -14.7% consensus); Net Profit: € 39.0 M (-36.1% vs. -36.4% BS(e) and -18.0% consensus); FY2024 vs. FY2023 Results Sales: € 4.571 Bn (-0.8% vs. -4.2% BS(e) and -4.2% consensus); EBITDA: € 1.352 Bn (-11.2% vs. -14.5% BS(e) and -13.4% consensus); EBIT: € 1.225 Bn (-2.0% vs. -5.5% BS(e) and -2.8% consen...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.